“quanticel-pharmaceuticals” Archives

in
Entry Author Date Location
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial 09/18/17 Boston
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
In New York and Montreal, Versant Seeds Two New Biotech Startups 12/10/15 New York
Avalon Debuts Three More Tiny Biotechs In Risk-Share Deal With GSK 06/15/15 San Diego
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
West Coast Biotech Roundup: Kythera, Amgen, Otonomy, Versant & More 04/30/15 San Diego
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
In Venture Reinvention, Versant Sees Gains Amid Biotech Boom Times 04/29/15 National
Any Given Cell: Can Biotech Pioneer Steve Fodor Do it Again? 02/13/15 San Francisco
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Celgene To Pump $45M into Quanticel to Discover Cancer Drugs, Gets Option To Acquire 11/04/11 San Francisco
Page 1 of 1